Period:
Draw Mode:
| Volume | 34,120 |
|
|||||
| News | - | ||||||
| Day High | 4.55 | Low High |
|||||
| Day Low | 4.358 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Check Cap Ltd | CHEK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.045 | 1.03% | 4.405 | 14:50:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.40 | 4.358 | 4.55 | 4.36 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 211 | 34,120 | $ 4.45 | $ 151,736 | - | 1.22 - 6.5398 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:50:41 | 100 | $ 4.405 | USD |
Check Cap Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 25.77M | 5.85M | - | 0 | -19.11M | -3.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Check Cap News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHEK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.42 | 4.625 | 3.4103 | 4.09 | 149,817 | 0.985 | 28.8% |
| 1 Month | 2.35 | 4.625 | 2.3361 | 3.66 | 108,435 | 2.06 | 87.45% |
| 3 Months | 2.97 | 4.625 | 2.29 | 3.36 | 102,445 | 1.44 | 48.32% |
| 6 Months | 1.32 | 4.625 | 1.25 | 2.75 | 89,350 | 3.09 | 233.71% |
| 1 Year | 6.01 | 6.5398 | 1.22 | 4.05 | 144,159 | -1.61 | -26.71% |
| 3 Years | 6.86 | 89.80 | 1.22 | 33.48 | 3,062,825 | -2.46 | -35.79% |
| 5 Years | 79.638 | 89.80 | 1.22 | 30.02 | 2,246,530 | -75.23 | -94.47% |
Check Cap Description
| Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. |